/

Niraparib

CAS 1038915-60-4

Overview

Niraparib, sold under the brand name Zejula, is an anti-cancer medication used for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is taken by mouth. It is a PARP inhibitor

Anant Labs manufacture and furnish high quality Niraparib impurities for global markets. Our Niraparib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Niraparib

Niraparib

CAS: 1038915-60-4
Mol. Formula: C₁₉H₂₀N₄O
Mol. Weight: 320.396

Impurities (4)

Chemical structure of 3-Methyl-2-nitrobenzoic acid

3-Methyl-2-nitrobenzoic acid

Cat. No.: ANT-NPB-01
CAS: 5437-38-7
Mol. Formula: C₈H₇NO₄
Mol. Weight: 181.15

Chemical structure of Methyl 3-formyl-2-nitrobenzoate

Methyl 3-formyl-2-nitrobenzoate

Cat. No.: ANT-NPB-03
CAS: 138229-59-1
Mol. Formula: C₉H₇NO₅
Mol. Weight: 209.16

Chemical structure of Methyl 3-(hydroxymethyl)-2-nitrobenzoate

Methyl 3-(hydroxymethyl)-2-nitrobenzoate

Cat. No.: ANT-NPB-04
CAS: 1331954-75-6
Mol. Formula: C₉H₉NO₅
Mol. Weight: 211.17

Chemical structure of Methyl 3-methyl-2-nitrobenzoate

Methyl 3-methyl-2-nitrobenzoate

Cat. No.: ANT-NPB-02
CAS: 5471-82-9
Mol. Formula: C₉H₉NO₄
Mol. Weight: 195.17